| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mereo BioPharma Group plc | Director | American Depositary Shares representing Ordinary Shares | 25.1K | $100K | $3.99 | Jun 17, 2024 | Direct |
| Mereo BioPharma Group plc | Director | Share Options (Right to buy) | 55K | $55.6K | $1.01 | Feb 5, 2025 | Direct |
| X4 Pharmaceuticals, Inc | Director | Common Stock | 5.56K | $1.06K | $0.19 | Jun 9, 2025 | Direct |
| Invivyd, Inc. | Director | Stock Option (Right to Buy) | 50K | May 23, 2023 | Direct | ||
| Mereo BioPharma Group plc | Director | Deferred Restricted Stock Units | 30.5K | Feb 5, 2025 | Direct | ||
| Tvardi Therapeutics, Inc. | Director | Stock Option (right to buy) | 12K | Apr 17, 2025 | Direct | ||
| LogicBio Therapeutics, Inc. | Director | Common Stock | 0 | $2.01 | Nov 16, 2022 | Direct | |
| LogicBio Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Nov 16, 2022 | Direct |